EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neuroprotective Effects of Esketamine in Central Nervous System Disorders: Mechanisms and Cellular Targets

Chendi Zhao, Yan Wang, Jinglang Wu, Hong Cheng iD

Basic & Clinical Pharmacology & Toxicology · 2026

DOI: 10.1111/bcpt.70221 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2026. Verfasst von Chendi Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Hospital of Hebei University, Baoding, Hebei, China. Hauptthemen laut MEDLINE: Neuroprotective Agents, Central Nervous System Diseases, Ketamine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 167 Literaturangaben. Gefördert von: Science and Technology Plan Project of Baoding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esketamine (ESK), the dextrorotatory enantiomer of ketamine, is an antagonist of the N‐methyl‐D‐aspartic acid (NMDA) receptor. ESK is considered an effective anesthetic because of its ability to mitigate postoperative pain and opioid use. Recently, it has attracted significant research attention for its fast‐acting antidepressant effects. Given the advantages of ESK in both perioperative and postoperative contexts, foundational research into this molecule is progressively moving forward. Accumulating evidence suggests that ESK possesses anti‐inflammatory, antiapoptotic and antioxidant characteristics in various diseases. This review summarizes the neuroprotective effects of ESK in central nervous system (CNS) disorders. ESK‐mediated cellular processes, including neuronal apoptosis, microglial polarization and astrocytic functions, are also summarized. In addition, the underlying molecular mechanisms of ESK are discussed, with a focus on inflammatory pathways and signalling cascades in neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsCentral Nervous System DiseasesKetamineHumansAnimalsReceptors, N-Methyl-D-AspartateSignal TransductionApoptosisNeuronsAntioxidantsAnti-Inflammatory Agents

Stichwörter der Autor:innen

central nervous systemesketamineinflammationneuroprotectionsignalling pathway

Substanzen

Neuroprotective AgentsKetamineReceptors, N-Methyl-D-AspartateEsketamineAntioxidantsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Anesthesiology, Affiliated Hospital of Hebei University, Baoding, Hebei, China.
  • Department of Neurosurgery, Affiliated Hospital of Hebei University, Baoding, Hebei, China.

ORCID-Profile: Hong Cheng

Förderung

  • Science and Technology Plan Project of Baoding

Zitieren

APA

Zhao, C., Wang, Y., Wu, J., & Cheng, H. (2026). Neuroprotective Effects of Esketamine in Central Nervous System Disorders: Mechanisms and Cellular Targets. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70221

Vancouver

Zhao C, Wang Y, Wu J, Cheng H. Neuroprotective Effects of Esketamine in Central Nervous System Disorders: Mechanisms and Cellular Targets. Basic & Clinical Pharmacology & Toxicology. 2026. doi:10.1111/bcpt.70221

BibTeX
@article{Zhao2026,
  author = {Zhao, Chendi and Wang, Yan and Wu, Jinglang and Cheng, Hong},
  title = {Neuroprotective Effects of Esketamine in Central Nervous System Disorders: Mechanisms and Cellular Targets},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2026},
  doi = {10.1111/bcpt.70221}
}
Kostenlos starten →